Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
424.43
+6.28 (1.50%)
At close: Jun 9, 2026, 4:00 PM EDT
426.00
+1.57 (0.37%)
After-hours: Jun 9, 2026, 7:53 PM EDT
Elevance Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $415.81. The average 1-year stock price forecast is 2.03% lower than the current stock price, while the lowest is $331 (-22.01%) and the highest is $498 (+17.33%).
Price Target: $415.81 (-2.03%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 12 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 8 | 8 | 8 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $411 → $476 | Buy | Maintains | $411 → $476 | +12.15% | Jun 8, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $435 → $465 | Buy | Maintains | $435 → $465 | +9.56% | Jun 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $391 | Buy | Maintains | $391 | -7.88% | Jun 4, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $352 → $404 | Hold | Reiterates | $352 → $404 | -4.81% | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $435 → $460 | Buy | Maintains | $435 → $460 | +8.38% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
194.22B
from 199.13B
Decreased by -2.46%
Revenue Next Year
198.49B
from 194.22B
Increased by 2.20%
EPS This Year
26.91
from 30.29
Decreased by -11.17%
EPS Next Year
29.25
from 26.91
Increased by 8.70%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 197.9B | ||
| Avg | 194.2B | ||
| Low | 190.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.6% | ||
| Avg | -2.5% | ||
| Low | -4.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.25 | ||
| Avg | 26.91 | ||
| Low | 26.72 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -6.7% | ||
| Avg | -11.2% | ||
| Low | -11.8% |